New Way to Stimulate Your Pancreas

1078

Prandin (repaglinide), a new type 2 oral medication manufactured by Novo Nordisk, has been approved by the FDA.

The new drug stimulates the secretion of insulin from the pancreas. It was created with a quick onset and short duration of action to be especially effective at mealtimes.

Bill Poole, president of Novo Nordisk, claims that Prandin helps “people with type 2 manage their diabetes at mealtimes. Prandin is a highly potent, fast-working agent that is absorbed rapidly after dosing and clears quickly from the bloodstream.”

Prandin is expected to be available in the United States in the spring of this year.

Click here to view/write comments
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.